Provider: CommonHealth's HLS and ProCom

HLS's Company Profile
HLS, part of CommonHealth, has excelled as a provider of scientific message-focused programming delivered by using dynamic innovative media options that address the modern pharmaceutical market needs. HLS employs approaches that connect the insights of opinion leaders with the clinical realities of community-based physicians to create relevant and patient-focused educational materials and tools. All programs include appropriate performance metrics. Global access and capabilities are provided in affiliation with CommonHealth's European offices.

Services and Offerings
  • Medical Expert and Advocacy Development 
  • Publication Planning
  • Domestic and Global Tactical Optimization
  • Congress Planning
Content Development:
  • Publication Execution
  • Faculty Development
  • Content Dissemination Planning
New Technology Solutions:
  • Content Asset Management Systems
  • Electronic Opinion Leader Identification and Engagement

ProCom's Company Profile
ProCom, part of CommonHealth, creates and delivers educational programs across multiple channels. The foundation of ProCom's success is an experienced medical and strategy team that can take complex scientific concepts and distill them into evidence-based scientific solutions, with key messages that clearly communicates to specific audiences and leverages technology. Our continuous interaction with KOLs across therapeutic areas ensures the educational content we develop is meaningful and timely. The results are highly scientific and strategically focused communication programs that have educational value that resonates with HCPs.

Services and Offerings
  • Advisory Boards
  • Communication Planning and Execution
  • Dinner Meetings and Symposia
  • Investigator and Protocol Meetings
  • Journal Supplements and Publications
  • KOL Engagement Planning and Implementation
  • Medical Strategy Planning and Execution
  • Monographs and Scientific Slide Decks
  • Opinion Leader Roundtables
  • Speaker Bureau Management and Training
  • Web-based Educational Programs

You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.